Background: Treatment of drug-resistant tuberculosis is often based on drug susceptibility testing results. Thus simple, rapid and economic test is very important for diagnosis of drug resistant tuberculosis and such method aids in TB control effectively. One such method is a Nitrate Reductase Assay (NRA).
INTRODUCTION
Tuberculosis (TB) is a serious public health problem in many developing countries. The drug resistant tuberculosis (DR-TB) and particularly multi-drug resistant tuberculosis (MDR-TB), defined as resistance to at least the two major anti-tuberculosis drugs isoniazid (INH) and rifampicin (RFP), has emerged in many countries in different regions of the world (WHO, 2009).
In Nepal, tuberculosis is a major public health problem and recognized by the Government as a priority number one (P 1 ) program. About 45% of the total population is infected with TB, out of which 60% are adult. Every year about 40,000 people develop TB, of whom 20,000 have infectious pulmonary disease. Introduction of treatment by DOTS has already reduced the number of death, however it is estimated 5000-7000 people still die per year from TB (NTC, 2008) . A national prevalence of MDR-TB is 2.9% among new TB cases and 11.7% among previously treated TB cases (STAC, 2008) Rapid and precise diagnosis of drug resistant tuberculosis is necessary for effective patient treatment and to prevent transmission of the disease. Isolation, identifi cation and susceptibility testing are essential procedures that should be performed as quickly as possible, so that adequate treatment can be prescribed. The drug susceptibility test currently available is the conventional proportion method on Lowenstein-Jensen (LJ) medium, which takes 4-6 weeks to yield culture result plus another 4-6 weeks for drug susceptibility test results. More rapid tests using liquid media, such as the BACTEC 460TB radiometric method and the MGIT, require specifi c equipment and consumables, and are expensive. Likewise, the new rapid tests based on molecular tools are generally not easy to use and need specialized staff. Rapid diagnosis of MDR patients is nevertheless necessary to avoid the spread of MDR strains. For developing countries, like Nepal the test should be specifi c, simple and applicable that can rapidly detect MDR Mycobacterium tuberculosis strains.
One rapid drug susceptibility testing method that could potentially satisfy these criteria is a Nitrate Reductase Assay, a colorimetric assay also known as Griess method (Golyshevskaia et al. 1996) . This assay was initially developed at the Central Tuberculosis Research Institute in Moscow, Russia, where it was called the Griess method, after J.P. Griess, who discovered the chemistry of the detection method used (Griess and Benerkungen, 1879) . It is a low-cost DST method that can be employed in areas of limited resources and low technical capacity (Canetti et al., 1969) . It is based on the ability of M. tuberculosis to reduce nitrate to nitrite, which is routinely used for biochemical identifi cation of mycobacterial species. The presence of nitrite can easily be detected with specifi c reagents, which produce a color change (Kent and Kubica, 1985) .
METHODOLOGY
Specimen processing: Sputum specimens were initially processed by modifi ed petroff's method and ZN acid-fast bacilli (AFB) staining of the sediment was done according to standard protocols (WHO, 1998).
Conventional
Lowenstein-Jensen method: Processed specimen was cultured on two slopes of LJ-medium and drug susceptibility test of isolate was performed by 1% proportion method according to standard protocols (WHO, 1998).
Nitrate Reductase Assay method :
Media preparation : Complete LJ-media was prepared and then 1g/1000 ml NaN0 3 was added to LJ medium and completely dissolved by stirring. The drugs were then added to the modifi ed medium to prepare the drug containing medium and the medium was a liquated and inspissated. Six tubes with modifi ed LJ medium are needed for each specimen: one containing INH at critical concentration (0.2 μg/ ml), one containing RFP at critical concentration (40 μg/ml), one containing SM at critical concentration (4 μg/ml), one containing EMB at critical concentration (2 μg/ml) and two control tubes without any drugs added.
Procedure :
The test was performed only on specimens with an AFB smear positive result (1+and above). Each of the six tubes described above was inoculated with 0.2 ml of the processed sputum sediment. After 28 days of incubation at 37 o C, 0.5 ml of freshly prepared Griess reagent was transferred into one of the growth control tubes, and development of color was observed. If the color intensity was suffi cient, the same amount of Griess reagent was pipetted into each of the drug containing tube and other control tube. The color intensity in the drug-containing tube was then compared to the control tube.
Interpretation of results :
The results were classifi ed as negative if there were no color changes or a very pale pink color was observed. Positive results varied from pink to deep red or violet. The results were thus, interpreted as follows:
Resistant (R) -An isolate was considered resistant to a certain drug if there was a positive color change in the drug tube in question and in the drug-free control tube.
Sensitive (S) -An isolate was considered sensitive to a drug if there was no color change in the drug tube in question and positive color change in the drug-free control tube.
If no color changes or pale pink color were observed in the control tube, the test was considered to be invalid.
Preparation of Griess reagent :
Shortly before use, one part of 50% (vol/vol) concentrated hydrochloric acid was mixed with two parts of 0.2% (wt/vol) sulfanilamide and two parts of 0.1% (wt/vol) n-1-naphthylenediamine dihydrochloride.
Preparation of inoculum : 1ml sterile distilled water was added to the sediment obtained after processing the sputum specimen.
RESULTS
The test was completed on 121 specimens of 144 smear-positive (31 1+, 31 2+ and 82 3+) specimens. Of the remaining 23 specimen for which the test was not completed, 12 were culture-negative by both gold standard and Nitrate reductase assay method and 11 were contaminated on culture by either one or both methods.
Comparison of the Nitrate Reductase Assay results with conventional drug susceptibility test result for 121 specimens is depicted in the Tables 1a and 1b. Among 28 strains that were resistant to INH by the conventional method, 28 (100%) were also found to be resistant by the nitrate reductase assay method. 
DISCUSSION
In this study, high sensitivity and specifi city of the nitrate reductase assay method, relative to conventional methods were demonstrated in the identifi cation of resistance of M. tuberculosis to four primary anti-tubercular drugs i.e. INH, RFP, SM and EMB. The sensitivity and specifi city of the direct nitrate reductase assay for detection of isoniazid resistance was 100% and 91%, for rifampicin was 100% and 98.95%, for streptomycin was 96% and 91.66% and for ethambutal was 100% and 98% respectively.
In a similar study by sloutsky et al. (2005) in Lima, Peru showed the sensitivity and specifi city of the method for INH resistance was 99.1% and 100%, and for RMP resistance was 93.5% and 100% respectively. Study by Angeby et al. (2005) showed sensitivity and specifi city of the direct NRA using the direct proportion method as reference for INH, RFP, SM, and EMB were 100 and 100% , 93 and 100% , 76 and 100% and 55 and 100% respectively. In another report by Angeby et al. (2002) , sensitivities and specifi cities for drugs as determined by the NRA method compared to those determined by the BACTEC 460 method were 100% and 100% for rifampicin, 97% and 96% for isoniazid, 95% and 83% for streptomycin, and 75% and 98% for ethambutol, respectively. Other study of the performance of the indirect NRA method by Golyshevskaia et al (1996) in Sweden, sensitivity and specifi city for INH were 97% and 96% respectively, and 100% for RMP.
The spread of multidrug-resistant (MDR) strains of Mycobacterium tuberculosis is an increasing public health concern in many parts of the world, especially in low-income countries, where most cases occur. The time lag to diagnose this is a signifi cant threat to the patient, the community, and health care workers. So, earlier identifi cation of MDR-TB cases is important as this would minimize the risk of disease progression and amplifi cation of drug resistance due to optimal therapy. Conventional DST requires on an average 20-40 days for initial culture growth, plus an additional Other low-cost methods have been proposed, such as the MTT or resazurin assays (Palomino et al., 2004) . They have been shown to be comparable to the NRA, at least for RFP when performed indirectly (Palomino et al., 2004) . However, they make use of liquid medium in a microplate format and that makes the techniques more complex and might also constitute a biohazard. Instead, the NRA utilizes standard solid L-J medium, although with NaNO 3 incorporated and (apart from being safer), it could therefore be easily adopted in any culture laboratory.
The ability to reduce nitrate is typical for M. tuberculosis, although some other mycobacterial species, like Mycobacterium kansasii, and most rapid growers share this characteristic (Kent and Kubica, 1985) . Nitrate reductase-negative strains of M. tuberculosis are rare (1%) (Kent and Kubica, 1985) and would create no false results since the control would be negative and the test would therefore be invalid. No such strains were encountered in this study. Strains of Mycobacterium bovis do not reduce nitrate, for which reason the NRA technique is not applicable to DST of them. Another possible limitation is that nitrite might be further reduced to nitric oxide, which cannot be detected by the reagents used. When the nitrate reduction test is performed for the purpose of species identifi cation, zinc powder is added to all negative tubes (Kent and Kubica, 1985) . Zinc reduces nitrate rapidly, and a true negative test will directly turn red, while there will be no color change in a tube where reduction has passed beyond nitrite. Since the result was always confi rmed, this step was omitted in this study. However, further studies will be needed to clarify the role of zinc powder in the NRA.
This study demonstrates the potential usefulness of the direct NRA as a rapid, susceptible and specifi c screening tool for MDR-TB. Even though more studies are needed to further assess the accuracy and applicability of the method, the direct nitrate reductase assay has the potential to become an inexpensive alternative for DST where resources are scarce, especially for RFP, the most important antituberculosis drugs. It might then be used either as a rapid screening tool alone or in combination with other methods. In addition to its rapidicity, the direct NRA has further obvious benefi ts that would facilitate its institution in resource poor setting. Furthermore, the test uses only simple reagents that are inexpensive and easily obtained, does not require maintenance of any specialized equipment, and requires minimal laboratory space and staffi ng.
CONCLUSION
In this study, direct NRA test for culture and susceptibility testing was evaluated in comparison to gold standard proportion method. The method was found to be having high sensitivity and specifi city. This study revealed that the direct nitrate reductase assay method has capability of accurate and rapid drug susceptibility testing for primary four anti-tuberculosis drugs viz, INH, RFP, SM, and EMB. More importantly, the test will provide patients and clinicians with the benefi ts of greater access to fast and accurate drug susceptibility testing result for these fi rst-line drugs.
